v3.26.1
Note 2 - Summary of Significant Accounting Policies (Tables)
12 Months Ended
Dec. 31, 2025
Notes Tables  
Schedule of Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Table Text Block]
   

As of December 31,

 
   

2025

   

2024

 

Cash and cash equivalents

  $ 7,958     $ 430  

Restricted cash included in other assets

    267       477  

Total cash, cash equivalents, and restricted cash in the Consolidated Statements of Cash Flows

  $ 8,225     $ 907  
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
   

For the years ended

December 31,

 
   

2025

   

2024

 

Numerator for basic and diluted income (loss) per share:

               

Net loss from continuing operations

  $ (33,222 )   $ (8,750 )

Less: Increase to accumulated deficit due to adjustment to common stock warrants exercise price

          1,005  

Less: Increase to accumulated deficit due to adjustment to Preferred Stock conversion price

          380  

Net loss from continuing operations attributable to common stockholders

  $ (33,222 )   $ (10,135 )

Net income from discontinued operations, net of taxes

    11,081       1,527  

Net loss

  $ (22,141 )   $ (8,608 )
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]
   

As of December 31,

 
   

2025*

   

2024*

 

Shares issuable upon conversion of Unsecured Convertible Notes

    7,143       21,429  

Common stock equivalent of Series B Non-Voting Convertible Preferred Stock (the “Series B Preferred Stock”)

    3,013       3,013  

Stock options and RSUs

    18,201       1,372  

Stock warrants

    1,098,248       2,167,279  
      1,126,605       2,193,093